Hope floats for Covid-19 vaccine candidates in India
The DCGI has given the nod for two vaccines and phase 1 of the vaccination process is expected to begin soon. Zydus Cadila’s vaccine candidate has also been cleared for phase 3 trials.
biocon
January 2021
November 2020
April 2020
February 2020
January 2020
October 2019
July 2019
January 2019
Biocon’s biosimilar biz tops $4 bn in valuation
Abu Dhabi-based sovereign wealth fund ADQ has picked up 1.80% stake in Biocon Biologics for $75 million; The company already raised $255 million from global marquee investors last year.
Healthcare leaders shine in MPW 2020 list
Cipla’s Samina Hamied, Lupin’s Vinita Gupta biggest rank gainers from the sector.
‘Restart economy sooner than later’
India is likely to recover faster than the rest of the world from the economic turmoil caused by Covid-19, with new opportunities presenting themselves, says Biocon chairperson.
SC agrees to amend order making Covid-19 tests free
An earlier judgment by the apex court making Coronavirus tests free across the board had sparked concerns over the viability of the private sector’s participation in testing for the virus.
Shaw named EY Entrepreneur of the Year
The award recognises entrepreneurs who, with their disruptive ideas and passion for growth, are creating successful global enterprises.
True North invests ₹536 crore in Biocon arm
The private equity firm’s investment values Biocon Biologics at about $3 billion on a pre-money equity basis.
Biocon’s biologics portfolio comes into its own
Bengaluru-based Biocon’s portfolio of biologic drugs has grown rapidly in the last five years and the company wants it to be a $1 billion business by 2022.
Good blueprint, but gaps remain: India Inc.
Focus on infra, housing, financial services, labour reforms welcome; but concerns remain on corporate tax, ability to meet disinvestment target.
Interim Budget 2019: What Kiran Mazumdar-Shaw expects
Here’s what the Biocon MD and chairperson expects from the interim Budget 2019.
